Enliven Therapeutics (NASDAQ:ELVN) Trading 11.3% Higher – Still a Buy?
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) rose 11.3% on Wednesday . The company traded as high as $23.08 and last traded at $22.78. Approximately 89,742 shares were traded during trading, a decline of 61% from the average daily volume of 228,633 shares. The stock had previously closed at $20.46. Analyst Ratings Changes ELVN […]
More Stories
It’s ‘Very Unlikely’ Supreme Court Will Overturn Trump’s Tariffs, Bessent Says
By Jack Phillips Treasury Secretary Scott Bessent on Jan. 18 said he believes it’s unlikely the U.S. Supreme Court will...
FBI Announces $100,000 Reward After Government Vehicles Broken Into in Minneapolis
By Jack Phillips The FBI said it is offering a reward of up to $100,000 for information leading to the...
Putin Invited to Join Gaza Board of Peace, Kremlin Says
By Guy Birchall The Kremlin confirmed on Jan. 19 that Russian President Vladimir Putin had been invited to join U.S....
Iran Protest Death Toll Nears 4,000, Human Rights Group Says
By Guy Birchall The U.S.-based Human Rights Activists News Agency (HRANA) said on Jan. 18 that it estimates at least...
All of Us Are Dead Season 2: Release Date, Cast, Trailer, and Updates
The Korean drama “All of Us Are Dead” was first released on January 28, 2022. Upon its release, the series...
Who is Milo Manheim Dating? Know About the ‘Tangled’ Lead Character
Milo Manheim, the actor, rose to fame from the Zombies franchise on Disney television films. His other films, like Journey...